| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Passage BIO, Inc. | PRESIDENT AND CEO, Director | Common Stock | 6,524 | $58,650 | $8.99 | 08 Jan 2026 | Direct |
| Passage BIO, Inc. | PRESIDENT AND CEO, Director | Employee Stock Option (right to buy) | 779,533 | 15 Mar 2025 | Direct | ||
| Passage BIO, Inc. | PRESIDENT AND CEO, Director | Restricted Stock Unit | 10,000 | 08 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PASG | Passage BIO, Inc. | 08 Jan 2026 | 3 | -$75,159 | 4 | PRESIDENT AND CEO, Director | 12 Jan 2026, 16:03 |
| PASG | Passage BIO, Inc. | 15 Mar 2025 | 1 | $0 | 4 | PRESIDENT AND CEO, Director | 18 Mar 2025, 17:11 |
| PASG | Passage BIO, Inc. | 15 Jan 2025 | 1 | $0 | 4 | PRESIDENT AND CEO, Director | 29 Dec 2025, 16:14 |
| PASG | Passage BIO, Inc. | 15 Mar 2024 | 1 | $0 | 4 | PRESIDENT AND CEO, Director | 19 Mar 2024, 16:09 |
| PASG | Passage BIO, Inc. | 15 Mar 2023 | 1 | $0 | 4 | President and CEO, Director | 05 Apr 2023, 19:29 |
| PASG | Passage BIO, Inc. | 10 Oct 2022 | 1 | $0 | 4 | Chief Executive Officer, Director | 12 Oct 2022, 16:08 |
| PASG | Passage BIO, Inc. | 10 Oct 2022 | 0 | $0 | 3 | Chief Executive Officer, Director | 12 Oct 2022, 16:06 |